Zobrazeno 1 - 10
of 122
pro vyhledávání: '"E. Tabachnik"'
Autor:
I. A. Barkov, I. V. Ernst, A. S. Rodin, M. A. Stepanov, I. E Tabachnik, F. M. Myskin, Ya. S. Semyonov
Publikováno v:
Okhrana truda i tekhnika bezopasnosti na promyshlennykh predpriyatiyakh (Labor protection and safety procedure at the industrial enterprises). :66-75
The authors have developed an integrated approach and technology for building an exoskeleton that minimizes human energy expenditures while walking. Optimized torque characteristics from an exoskeleton worn on one knee have reduced metabolic and elec
Publikováno v:
Acta Paediatrica. 89:1018-1020
Publikováno v:
physica status solidi (b). 179:411-418
Exciton states of LiH1−xFx in the exciton band of lithium hydride are investigated by optical methods. It was found that spectra of the lowest-energy exciton band of these crystals follow the persistent type of behaviour. The relation of exciton en
Autor:
A. Augarten, J Yahav, Z Barzilay, E Tabachnik, S Benzaray, Amir Szeinberg, H Roizin, D Har-Even, M Molho
Publikováno v:
Thorax. 48:906-910
BACKGROUND--The population of Israel consists of immigrants from many different countries. It is not known whether a single nomogram can be used for spirometric values of children of different ethnic descent. METHODS--Spirometry was performed in 753
Publikováno v:
physica status solidi (b). 175:K27-K30
Publikováno v:
Clinical Experimental Allergy. 20:389-393
In the present study we assessed the effect of leukotriene C4 on ciliary beat frequency in vitro. Chicken tracheas were sliced into thin rings and ciliary activity was viewed microscopically. Ciliary beat frequency was measured through an optical fib
Publikováno v:
Pediatric Pulmonology. 18:119-121
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 89(8)
Publikováno v:
The British journal of clinical practice. 48(1)
This study was conducted to assess the long-term safety of fluticasone propionate 50 micrograms twice daily (100 micrograms/day) or 100 micrograms twice daily (200 micrograms/day) administered via a dry powder inhaler in children aged 4-17 years with